Agilent Technologies, Inc. is a global provider of analytical instruments, software, services, and consumables for laboratory workflows. Headquartered in Santa Clara, California, the company primarily serves the life sciences, diagnostics, and applied chemical markets. Originally established as a spin-off from Hewlett-Packard in 1999, Agilent focuses on enabling scientific research and clinical diagnostics.
Financial Statements
In thousands, USD
FY 2025
FY 2024
FY 2023
FY 2022
Total Revenues
6,948,000
6,510,000
6,833,000
6,848,000
Cost of Sales
3,305,000
2,975,000
3,368,000
3,126,000
Gross Profit
3,643,000
3,535,000
3,465,000
3,722,000
Selling, General & Administrative Expenses
1,709,000
1,568,000
1,634,000
1,637,000
Research & Development Expenses
455,000
479,000
481,000
467,000
Operating Profit
1,479,000
1,488,000
1,350,000
1,618,000
Interest and Investment Income
62,000
80,000
51,000
9,000
Interest Expense
(112,000)
(96,000)
(95,000)
(84,000)
Non-Operating Income
6,000
49,000
33,000
(39,000)
Total Non-Operating Income
(44,000)
33,000
(11,000)
(114,000)
Income Before Provision for Income Taxes
1,435,000
1,521,000
1,339,000
1,504,000
Provision for Income Taxes
132,000
232,000
99,000
250,000
Consolidated Net Income
1,303,000
1,289,000
1,240,000
1,254,000
Net Income Attributable to Common Shareholders
1,303,000
1,289,000
1,240,000
1,254,000
Basic EPS
4.59
4.44
4.22
4.19
Diluted EPS
4.57
4.43
4.19
4.18
Basic Weighted Average Shares Outstanding
284,000
290,000
294,000
299,000
Diluted Weighted Average Shares Outstanding
285,000
291,000
296,000
300,000
Shares Outstanding
283,054
285,193
292,123
295,259
FY 2025
FY 2024
FY 2023
FY 2022
Cash and Cash Equivalents
1,789,000
1,329,000
1,590,000
1,053,000
Total Cash and Cash Equivalents
1,789,000
1,329,000
1,590,000
1,053,000
Accounts Receivable
1,487,000
1,324,000
1,291,000
1,405,000
Total Trade Receivables
1,487,000
1,324,000
1,291,000
1,405,000
Inventories
1,025,000
972,000
1,031,000
1,038,000
Other Current Assets
293,000
334,000
274,000
282,000
Total Current Assets
4,594,000
3,959,000
4,186,000
3,778,000
Net Property, Plant & Equipment
2,023,000
1,778,000
1,270,000
1,100,000
Net Intangible Assets
445,000
547,000
475,000
821,000
Goodwill
4,473,000
4,477,000
3,960,000
3,952,000
Long-Term Investments
133,000
175,000
164,000
195,000
Other Long-Term Assets
1,059,000
910,000
708,000
686,000
Total Assets
12,727,000
11,846,000
10,763,000
10,532,000
Accounts Payable
570,000
540,000
418,000
580,000
Accrued Expenses
849,000
766,000
680,000
784,000
Short-Term Debt
304,000
45,000
—
36,000
Unearned Revenue
624,000
544,000
505,000
461,000
Total Current Liabilities
2,347,000
1,895,000
1,603,000
1,861,000
Long-Term Debt
3,050,000
3,345,000
2,735,000
2,733,000
Other Long-Term Liabilities
589,000
708,000
580,000
633,000
Total Long-Term Liabilities
3,639,000
4,053,000
3,315,000
3,366,000
Total Liabilities
5,986,000
5,948,000
4,918,000
5,227,000
Common Stock
3,000
3,000
3,000
3,000
Additional Paid-in Capital
5,575,000
5,450,000
5,387,000
5,325,000
Accumulated Other Comprehensive Income
(226,000)
(305,000)
(327,000)
(347,000)
Retained Earnings
1,389,000
750,000
782,000
324,000
Total Common Shareholders' Equity
6,741,000
5,898,000
5,845,000
5,305,000
Total Shareholders' Equity
6,741,000
5,898,000
5,845,000
5,305,000
Total Liabilities and Shareholders' Equity
12,727,000
11,846,000
10,763,000
10,532,000
FY 2025
FY 2024
FY 2023
FY 2022
Net Income
1,303,000
1,289,000
1,240,000
1,254,000
Depreciation & Amortization
288,000
257,000
271,000
317,000
Share-Based Compensation Expense
128,000
129,000
111,000
125,000
Other Adjustments
(29,000)
(7,000)
266,000
94,000
Changes in Trade Receivables
(149,000)
7,000
132,000
(321,000)
Changes in Inventories
(97,000)
34,000
(33,000)
(248,000)
Changes in Accounts Payable
16,000
103,000
(171,000)
121,000
Changes in Accrued Expenses
69,000
(12,000)
(91,000)
(22,000)
Changes in Other Operating Activities
30,000
(49,000)
47,000
(8,000)
Cash from Operating Activities
1,559,000
1,751,000
1,772,000
1,312,000
Capital Expenditure
(407,000)
(378,000)
(298,000)
(291,000)
Purchases of Investments
—
(5,000)
(8,000)
(13,000)
Proceeds from Sale of Investments
8,000
—
5,000
22,000
Payments for Business Acquisitions
4,000
(862,000)
(51,000)
(52,000)
Proceeds from Business Divestments
—
—
50,000
—
Other Investing Activities
1,000
(13,000)
(8,000)
(4,000)
Cash from Investing Activities
(394,000)
(1,258,000)
(310,000)
(338,000)
Issuance of Short-Term Debt
(42,000)
40,000
(35,000)
35,000
Net Issuance / (Repayments) of Short-Term Debt
(42,000)
40,000
(35,000)
35,000
Issuance of Long-Term Debt
4,000
1,197,000
—
600,000
Repayments of Long-Term Debt
(3,000)
(600,000)
—
(609,000)
Net Issuance / (Repayments) of Long-Term Debt
1,000
597,000
—
(9,000)
Issuance of Common Shares
72,000
77,000
67,000
58,000
Repurchases of Common Shares
(454,000)
(1,180,000)
(629,000)
(1,206,000)
Net Issuance / (Repurchases) of Common Shares
(382,000)
(1,103,000)
(562,000)
(1,148,000)
Common Share Dividends Paid
(282,000)
(274,000)
(265,000)
(250,000)
Other Financing Activities
(10,000)
(12,000)
(68,000)
—
Cash from Financing Activities
(715,000)
(752,000)
(930,000)
(1,372,000)
Effect of Exchange Rate Changes on Cash and Cash Equivalents
9,000
(2,000)
5,000
(36,000)
Increase / (Decrease) in Cash, Cash Equivalents and Restricted Cash